We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitco...
Read ArticleStocks surge and US dollar jumps as Trump leads ASX rises amid tight US election race Bitcoin hits...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleCardiex opens US pre-orders for the CONNEQT Pulse, targeting consumer arterial health monitoring Ov...
Read ArticleCardieX wins US$525,000 National Institutes of Health award for innovation in treatment of hyperten...
Read ArticleASX falls as tech sector drops on Euro chipmaker ASML’s report Gold prices near record highs wit...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleCardiex shares climb 15% on news the company is set to surpass its FY24 revenue projections Company...
Read ArticleASX rose as the RBA held interest rates at 12-year high 4.35pc All 11 sectors on the ASX gained, w...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleLocal markets are lucky to close a smidgen higher IT and Healthcare sectors offset a 2pc loss for...
Read ArticleRecce Pharma says Phase 1/2 study is achieving primary endpoints Cynata also reports also reports g...
Read ArticleStockhead’s Top 10 at 10, published each trading day, highlights the best (and worst) performing ASX...
Read Article14 million raise for CardieX consisted of a placement, shareholder entitlement offer, and a funding...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleBenchmark index settles almost -0.6% lower on Tuesday All sectors bar Healthcare and Financials in...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleASX 200 find 0.5% to start the week, LTR looks ready to sell Energy stocks and miners offset IT a...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleASX 200 closes about 0.06% in the green (so, really, we ended in the chartreuse) down -1.2 in Augus...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleMedical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI ai...
Read ArticleStroke has long been recognised as being among Australia’s most costly disease groups. It occurs wh...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleThe S&P ASX 200 was down 2.5% in May, with mid caps performing the best and small caps lagging...
Read ArticleThe market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts...
Read ArticleThe benchmark kicked off well at +0.8% before deflating to finish on +0.4% Utilities (+1.21%)win th...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleEquities research shop MST Access has upgraded its valuation on CardieX after the leading cardiovasc...
Read ArticleStockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have sl...
Read ArticleThe world’s first, customisable vascular biometric monitor has received regulatory clearance to prov...
Read ArticleCardieX jumps 16pc after getting FDA clearance for CONNEQT Pulse CONNEQT Pulse is a world first mul...
Read ArticleASX 200 benchmark closes 0.11% lower after a fickle day on the bourse Iron ore price drops to five...
Read ArticleAustralian Medtech CardieX has completed a $4.5million placement, continuing the company’s progress...
Read ArticleASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of...
Read ArticleRBA lifts rates 25 basis points, says there’s more where that came from ASX immediately sags 0.5% o...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleThe ASX puts on a late spurt to finish the day up 0.5% Star Entertainment and Bluescope in very hot...
Read ArticleHighlights The ASX 200 benchmark index closed in the green today (December 9), gaining 36.10 poi...
Read ArticleCardieX (CDX) subsidiary ATCOR pens a new clinical trial services agreement for its XCEL devices and...
Read ArticleASX 200 down 0.41% on lower than normal volume Small cap index falls 1.17% and 7 out 11 sectors f...
Read ArticleWell… that was Tuesday, everyone. We trust you’ve had a great day, and hope that the whims of the Ma...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleMedtech CardieX has successfully ruled off a $4.33 million placement to fast track the commercialisa...
Read ArticleHealth technology company CardieX (CDX) raises $4.33 million under its placement and launches a $1...
Read ArticleThe ASX200 is down 0.24% dragged down by the tech sector Eight out of eleven sectors were lower, wi...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleLiterally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeo...
Read ArticleCardieX (CDX) and its manufacturing partner, Andon, submit its blood pressure and arterial health m...
Read ArticleOrthocell jumps 35% after signing global license deal Imricor in with Siemens deal on 3D imaging sy...
Read ArticleCardieX is a step closer to launching its world first CONNEQT Pulse dual blood pressure monitor, aft...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe US FDA has classified CardieX’s (CDX) CONNEQT Companion app as a Medical Device Data System (MD...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleSupply chains are constrained globally as the world gets back on its feet This comes as inflation t...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleCardieX unveils the TicWatch GTH Pro made by global consumer electronics company Mobvoi using techn...
Read ArticleThe ASX200 has come to a jerky halt, closing more than 50 points or 0.7% higher. The market is down...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleSo basically, this is how I read it. Because of two really screwball takeover ideas involving the A2...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleCardieX’s (CDX) subsidiary teams up with Andiwn Scientific for a global clinical trial of ATCOR XCE...
Read ArticleLocal stocks end up posting a solid session on Monday, following some steady gains on Wall Street on...
Read ArticleASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 bein...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleAnalysts have labelled CardieX and its blood pressure tech a Christmas buy for growth in 2022. A le...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleCardieX and Mobvoi are poised to release a world-first consumer smartwatch with proprietary heart-he...
Read ArticleCardieX takes a step closer to world first wearable after signing manufacturing deal with Shenzhen-b...
Read ArticleWhile Apple fanatics eagerly await its next smartwatch with a heart monitor, there are a couple of A...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThere’s no doubt there’s a building boom right now in the US, with the Biden administration investin...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleStockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly resu...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleIt’s been a big few weeks for CardieX (ASX:CDX) as the health technology company restructured itself...
Read ArticleSummary Little Green Pharma (ASX:LGP) boosts growth strategy, acquires production facility in De...
Read ArticleSummary The ASX 200 closed 1.48% higher at 7,342.20, recouping previous session losses. Ten of...
Read ArticlePlenty of action on the biotech front today has provided ASX investors with some mouth-watering gain...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleSummary The benchmark index was up today, with most of the indices trading in the green zone. a...
Read ArticleAustralian medtech CardieX has announced the launch of CONNEQT; a new consumer health division to fo...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSummary Health technology player CardieX Limited reported an impressive 29% growth in its sales...
Read ArticleThe Cardiex Ltd (ASX: CDX) share price is up 3.9% to 5.3 cents in afternoon trading after the compa...
Read ArticleThe Cardiex Ltd (ASX: CDX) share price was rising today as the company announced it had received a...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, September 16. Data is taken after the...
Read ArticleSpecial Report: CardieX has inked one of its most significant deals to date, securing a partnership...
Read ArticleSeasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the...
Read ArticleMedical technology company CardieX (ASX:CDX) says it has successfully completed a $2.5 milli...
Read ArticleDigital health technology company CardieX (ASX: CDX) has announced its wearables co-development part...
Read ArticleResearch house MST Access initiated coverage on Cardiex in September 2019 with an 8.2 cents per shar...
Read ArticleResearch house MST Access initiated coverage on Cardiex in September 2019 with an 8.2 cents per shar...
Read ArticleA wholly-owned subsidiary of CardieX (ASX: CDX) has become the world’s first company to develop a me...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleCardieX’s (CDX) subsidiary, ATCOR, has won a contract with Bayer AG to provide clinical trial servi...
Read ArticleAustralian health care sector is one of the fastest growing, dynamic and highly diversified sectors...
Read ArticleTechnology certainly plays a significant role in each segment of the industry, more so than ever, an...
Read ArticleCardieX Ltd (ASX:CDX) has entered into a JV with the largest Google wearable platform partner in Chi...
Read ArticleShares in CardieX (ASX:CDX) have spiked 54 per cent this morning to 3.7c, their highest point since...
Read ArticleDigital health technology company CardieX (ASX: CDX) has struck a multi-year deal with Mobvoi Inform...
Read ArticleRewardle Holdings Limited Social media company Rewardle Holdings Limited (ASX: RXH) connects more t...
Read ArticleUp until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘su...
Read ArticleUp until about four years ago obesity was an ‘it’ investment trend, as global funds spruiked the ‘su...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
